Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Galenica AG
  6. Summary
    GALE   CH0360674466

GALENICA AG

(GALE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
01/13/2022 01/14/2022 01/17/2022 01/18/2022 01/19/2022 Date
65.25(c) 64.7(c) 65.05(c) 63.75(c) 63.4(c) Last
68 409 91 971 117 613 81 546 104 635 Volume
-1.06% -0.84% +0.54% -2.00% -0.55% Change
More quotes
Estimated financial data (e)
Sales 2021 3 735 M 4 077 M 4 077 M
Net income 2021 156 M 171 M 171 M
Net Debt 2021 497 M 542 M 542 M
P/E ratio 2021 20,0x
Yield 2021 3,06%
Sales 2022 3 813 M 4 161 M 4 161 M
Net income 2022 160 M 174 M 174 M
Net Debt 2022 475 M 519 M 519 M
P/E ratio 2022 19,9x
Yield 2022 3,27%
Capitalization 3 138 M 3 428 M 3 425 M
EV / Sales 2021 0,97x
EV / Sales 2022 0,95x
Nbr of Employees 5 388
Free-Float 98,8%
More Financials
Company
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre... 
Sector
Drug Retailers
Calendar
03/15Earnings Release
More about the company
Ratings of Galenica AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about GALENICA AG
2021GLOBAL MARKETS LIVE : Oracle, Pfizer, Tesla, Amgen, Royal Dutch Shell...
2021Australia's CSL to buy Swiss drugmaker Vifor for $11.7 bln
RE
2021Vifor Pharma shares jump 15% as takeover talks with CSL confirmed
RE
2021AlphaValue/Baader Europe Lifts Price Target on Galenica, Maintains Add Recommendation
MT
2021AlphaValue/Baader Europe Lowers Price Target on Galenica, Maintains Add Recommendation
MT
2021GALENICA : AlphaValue/Baader Europe Lifts Price Target on Galenica AG
MT
2021GALENICA : AlphaValue/Baader Europe Lifts Price Target on Galenica
MT
2021GALENICA : Bank Vontobel Lifts Price Target on Galenica, Maintains Hold Recommendation
MT
2021Global markets live: Sanofi, Alphabet, BMW, Ford, Tencent...
2021GALENICA : half year results 2021
PU
2021GALENICA : Investor Presentation (Version August 2021)
PU
2021Galenica AG Raises Its Sales Guidance for the Fiscal 2021
CI
2021GALENICA : Lifts FY21 Sales Outlook As COVID-19 Self-Test Distribution Raises H1 Profit
MT
2021Galenica AG Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021GALENICA : acquires Lifestage Solutions Ltd.
PU
More news
News in other languages on GALENICA AG
01/18VIFOR : Australische CSL bestätigt Angebotspreis pro Aktie
01/02Mehrere grosse Arbeitgeber bauen laut Umfrage Zahl der Stellen aus
2021BOURSE ZURICH : début de semaine difficile pour le SMI
2021BOURSE ZURICH : le SMI voit rouge avant les fêtes de Noël
2021EN DIRECTO DESDE LOS MERCADOS : Rovi, Siemens Gamesa, Acerinox, Unibail, Ercros, Oracle, G..
More news
Analyst Recommendations on GALENICA AG
More recommendations
Chart GALENICA AG
Duration : Period :
Galenica AG Technical Analysis Chart | GALE | CH0360674466 | MarketScreener
Technical analysis trends GALENICA AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 63,40 CHF
Average target price 74,30 CHF
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Marc Werner Chief Executive Officer
Felix Fritz Burkhard Chief Financial Officer & Head-Investor Relations
Daniela Bosshardt-Hengartner Chairman
Lukas Ackermann Chief IT & Digital Services Officer
Michel Burnier Independent Director
Sector and Competitors